ArticleOncotarget2017

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers.

Sergey V Kozin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.